98 related articles for article (PubMed ID: 3791855)
21. Uterine sarcoma: analysis of prognostic variables in 71 cases.
Wheelock JB; Krebs HB; Schneider V; Goplerud DR
Am J Obstet Gynecol; 1985 Apr; 151(8):1016-22. PubMed ID: 2984936
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic factors in adenocarcinoma of the endometrium].
Giordana C; Malinverni G; Rosmino C; Del Tetto F; Ravarino N; Sala S
Radiol Med; 1991 Mar; 81(3):342-5. PubMed ID: 2014343
[TBL] [Abstract][Full Text] [Related]
23. Endometrial carcinoma: the role of irradiation.
Underwood PB; Taylor PT
Clin Obstet Gynaecol; 1986 Dec; 13(4):767-87. PubMed ID: 3791830
[TBL] [Abstract][Full Text] [Related]
24. [Follow-up of patients with tumors of the uterus treated with cobalt therapy and controlled for over 20 years].
Ottolenghi G; Oggero P; Mancuso S
Minerva Ginecol; 1986; 38(7-8):593-604. PubMed ID: 3748439
[No Abstract] [Full Text] [Related]
25. Prognostic value of thymidine phosphorylase immunostaining in patients with uterine cervical cancer treated concurrently with doxifluridine, radiotherapy and immunotherapy.
Sato S; Yajima A; Sasaki H; Mizutani K; Honjo H; Yamamoto K; Ozaki M; Hasegawa K; Kudo T; Yakushiji M; Hatae M; Noda K
Oncol Rep; 2001; 8(2):239-44. PubMed ID: 11182033
[TBL] [Abstract][Full Text] [Related]
26. [Surgical and radiologic treatment of cancer of the uterine body. Results of 12 years].
Di Pietrantonj F; Proietti A; Cardinali M; Fabbietti L; Di Furia L; Giulioni M
Minerva Med; 1993 Nov; 84(11):603-14. PubMed ID: 8015688
[TBL] [Abstract][Full Text] [Related]
27. [The value of and indications for radiotherapy in endometrial carcinoma].
Kucera H
Strahlenther Onkol; 1991 Jul; 167(7):381-6. PubMed ID: 1858012
[TBL] [Abstract][Full Text] [Related]
28. Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix carcinoma.
Varveris H; Kachris S; Mazonakis M; Lyraraki E; Petineli E; Varveris A; Fasoulaki A; Tzedakis A; Kouloulias V; Zolindaki A; Vlachaki M
Strahlenther Onkol; 2006 Mar; 182(3):125-34. PubMed ID: 16520906
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma of the endometrium.
Morgan DA
Clin Oncol; 1984 Jun; 10(2):187-9. PubMed ID: 6734011
[No Abstract] [Full Text] [Related]
30. [Neutron therapy of endometrial cancer using californium-252 sources of high activity].
Kiseleva VN; Savinova VF; Mar'ina LA; Chekhonadskiĭ VN
Vopr Onkol; 1988; 34(9):1070-4. PubMed ID: 3188432
[TBL] [Abstract][Full Text] [Related]
31. Uterine endolymphatic stromal myosis: a collaborative study.
Piver MS; Rutledge FN; Copeland L; Webster K; Blumenson L; Suh O
Obstet Gynecol; 1984 Aug; 64(2):173-8. PubMed ID: 6738952
[TBL] [Abstract][Full Text] [Related]
32. [Uterine sarcoma treated by surgery and postoperative radiation therapy. Patterns of relapse, prognostic factors and role of radiation therapy].
Coquard R; Romestaing P; Ardiet JM; Mornex F; Sentenac I; Gérard JP
Bull Cancer; 1997 Jun; 84(6):625-9. PubMed ID: 9295866
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
Le T
Eur J Surg Oncol; 2001 Apr; 27(3):282-5. PubMed ID: 11373106
[TBL] [Abstract][Full Text] [Related]
34. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.
Hornback NB; Omura G; Major FJ
Int J Radiat Oncol Biol Phys; 1986 Dec; 12(12):2127-30. PubMed ID: 3793549
[TBL] [Abstract][Full Text] [Related]
35. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
36. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.
Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E
Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496
[TBL] [Abstract][Full Text] [Related]
37. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
Kwon JS; Abrams J; Sugimoto A; Carey MS
Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450
[TBL] [Abstract][Full Text] [Related]
38. [A clinicopathological study on adenocarcinoma of the uterine cervix].
Yoshida K; Okuda H; Hayashi Y; Nakagiri Y; Sekiba K
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):261-5. PubMed ID: 2045694
[TBL] [Abstract][Full Text] [Related]
39. Endometrial carcinoma: 128 cases at stages I and II.
Benedetti Panici P; Di Roberto PF; Margariti PA; Scambia G; Bompiani A; Mancuso S
Gynecol Obstet Invest; 1987; 24(2):138-44. PubMed ID: 3653785
[TBL] [Abstract][Full Text] [Related]
40. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
